![]()
|
|
||||||||
J Biol Chem, Vol. 274, Issue 26, 18387-18392, June 25, 1999
,
,
,
From the Departments of Recent work has indicated that sigma receptor
ligands can modulate potassium channels. However, the only sigma
receptor characterized at the molecular level has a novel structure
unlike any other receptor known to modulate ion channels. This 26-kDa
protein has a hydropathy profile suggestive of a single
membrane-spanning domain, with no apparent regions capable of G-protein
activation or protein phosphorylation. In the present study patch clamp
techniques and photoaffinity labeling were used in DMS-114 cells (a
tumor cell line known to express sigma receptors) to investigate the role of the 26-kDa protein in ion channel modulation and probe the mechanism of signal transduction. The sigma receptor ligands N-allylnormetazocine (SKF10047), ditolylguanidine, and
(±)-2-(N-phenylethyl-N-propyl)-amino-5-hydroxytetralin all inhibited voltage-activated potassium current
(IK). Iodoazidococaine (IAC), a high affinity
sigma receptor photoprobe, produced a similar inhibition in
IK, and when cell homogenates were illuminated
in the presence of IAC, a protein with a molecular mass of 26 kDa was
covalently labeled. Photolabeling of this protein by IAC was inhibited
by SKF10047 with half-maximal effect at 7 µM. SKF10047 also inhibited IK with a similar
EC50 (14 µM). Thus, physiological responses
to sigma receptor ligands are mediated by a protein with the same
molecular weight as the cloned sigma receptor. This indicates that ion
channel modulation is indeed mediated by this novel protein.
Physiological responses were the same when cells were perfused
internally with either guanosine 5'-O-(2-thiodiphosphate) or GTP, indicating that signal transduction is independent of G-proteins. These results demonstrate that ion channels can be modulated by a receptor that does not have seven membrane-spanning domains and does not employ G-proteins. Sigma receptors thus modulate ion channels by a novel transduction mechanism.
Medicine,
Physiology,
and ** Pharmacology, University of Wisconsin School of Medicine,
Madison, Wisconsin 53706
This article has been cited by other articles:
![]() |
A. Pal, U. B. Chu, S. Ramachandran, D. Grawoig, L.-W. Guo, A. R. Hajipour, and A. E. Ruoho Juxtaposition of the Steroid Binding Domain-like I and II Regions Constitutes a Ligand Binding Site in the {sigma}-1 Receptor J. Biol. Chem., July 11, 2008; 283(28): 19646 - 19656. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Pal, A. R. Hajipour, D. Fontanilla, S. Ramachandran, U. B. Chu, T. Mavlyutov, and A. E. Ruoho Identification of Regions of the {sigma}-1 Receptor Ligand Binding Site Using a Novel Photoprobe Mol. Pharmacol., October 1, 2007; 72(4): 921 - 933. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Aydar, C. P. Palmer, and M. B. A. Djamgoz Sigma Receptors and Cancer: Possible Involvement of Ion Channels Cancer Res., August 1, 2004; 64(15): 5029 - 5035. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Zhang, S. Rajamani, Y. Chen, Q. Gong, Y. Rong, Z. Zhou, A. Ruoho, and C. T. January Cocaine Blocks HERG, but Not KvLQT1+minK, Potassium Channels Mol. Pharmacol., April 16, 2001; 59(5): 1069 - 1076. [Abstract] [Full Text] |
||||
![]() |
M. Schaefer, U. F. Habenicht, M. Bräutigam, and T. Gudermann Steroidal Sigma Receptor Ligands Affect Signaling Pathways in Human Spermatozoa Biol Reprod, July 1, 2000; 63(1): 57 - 63. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |